Mirapex (pramipexole), a drug used to treat symptoms of Parkinson’s disease and moderate to severe restless legs syndrome (RLS), may be linked to an increased risk of heart failure, according to a safety advisory issued by the Food and Drug Administration (FDA). Recent studies have suggested the potential for heart failure but the data is limited, thus the FDA says more review is needed before a definite risk can be established. The warning is based on a pooled analysis of randomized clinical trials that found heart failure was more frequent with Mirapex than with placebo; however, the results were not ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.